MarketCap
Facebook
X
Telegram
Kewaunee Scientific Corporation Income Statement 2026-2009 | KEQU
Brief overview of income trends at Kewaunee Scientific Corporation
The figures are compared over a five-year interval. The revenue attributed to Kewaunee Scientific Corporation moved from $148 million to $240 million between the two endpoints. The cumulative result was +63%, corresponding to roughly 10.3% per year. Top-line growth remained consistently strong over the period.
Gross profit changed from 23.4 million dollars to 68.9 million dollars (+193.9%). Direct costs grew more slowly than revenue and improved the economics of sales. Gross margin moved from 15.9% to 28.6%. The margin shift points to a more favorable sales-and-cost structure.
The five-year EBITDA result moved by +15629.7%: from −145 thousand dollars to 22.5 million dollars. Operating profitability strengthened faster than the scale of sales. Comparing the endpoints gives EBITDA margins of −0.1% and 9.4%. The increased EBITDA share is a positive sign.
Across the five years, the net result shifted from −$4.7 million to $11.4 million. A negative result turned positive over the five years.
Over the period, capitalization shifted from $26.3 million to $165 million (+527.3%). Capitalization moved ahead of the business fundamentals.
Conclusion
The financial trajectory looks strong and well balanced. The strongest signals are a stronger final result, a stronger gross margin and higher operating efficiency. The key question is whether sales can be converted into sustainable profit.
Annual Income Statement Kewaunee Scientific Corporation
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
103 M | 165 M | 136 M | 44.1 M | 43.5 M | 38.6 M | 26.3 M | 59.5 M | 88.7 M | 61.9 M | 44.4 M | 43.7 M | 42.4 M | 34 M | 20.9 M | 26.3 M | 31.7 M | - |
Shares |
2.86 M | 2.86 M | 2.88 M | 2.82 M | 2.79 M | 2.76 M | 2.75 M | 2.74 M | 2.72 M | 2.7 M | 2.67 M | 2.63 M | 2.61 M | 2.59 M | 2.58 M | 2.58 M | 2.56 M | - |
Historical Prices |
35.8 | 57.6 | 47.2 | 15.6 | 15.6 | 14.6 | 12.6 | 11.6 | 22.9 | 28 | 23.2 | 14.6 | 15.8 | 13.7 | 10.5 | 6.5 | 12.4 | 9.54 |
Net Income |
9.62 M | 11.4 M | 18.8 M | 738 K | -6.13 M | -2.98 M | -4.69 M | 1.53 M | 5.19 M | 4.52 M | 3.8 M | 3.53 M | 3.9 M | 3.04 M | 1.03 M | 1.85 M | 3.57 M | - |
Revenue |
282 M | 240 M | 204 M | 219 M | 169 M | 38.7 M | 148 M | 147 M | 158 M | 139 M | 129 M | 119 M | 111 M | 117 M | 103 M | 100 M | - | - |
Cost of Revenue |
202 M | 172 M | 152 M | 184 M | 145 M | 123 M | 124 M | 121 M | 126 M | 112 M | 105 M | - | - | - | - | - | - | - |
Gross Profit |
80.4 M | 68.9 M | 52.1 M | 35.6 M | 24.2 M | 6.06 M | 23.4 M | 25.3 M | 32 M | 26.6 M | 23.7 M | 21.8 M | 22 M | 22.3 M | 19.2 M | 19.3 M | 21.4 M | - |
Operating Income |
16.7 M | 17.8 M | 18.3 M | 5.36 M | -2.61 M | -1.32 M | -2.34 M | 2.11 M | 9.92 M | 6.54 M | 5.7 M | 5.23 M | 5.96 M | 5.28 M | 2.71 M | 3.16 M | 5.83 M | - |
Interest Expense |
- | - | 1.8 M | 1.73 M | 632 K | 389 K | 493 K | 367 K | 299 K | 292 K | 306 K | 325 K | 373 K | 362 K | 445 K | 199 K | 157 K | - |
EBITDA |
23 M | 22.5 M | 21.4 M | 8.23 M | 161 K | 1.37 M | -145 K | 4.68 M | 11.8 M | 9.24 M | 8.29 M | 7.84 M | 8.51 M | 7.93 M | 5.38 M | 5.64 M | 8.18 M | - |
Operating Expenses |
63.7 M | 51.1 M | 33.8 M | 30.2 M | 26.8 M | 25.3 M | 26.2 M | 23.2 M | 22.9 M | 20.1 M | 18 M | 16.5 M | 16.1 M | 17 M | 16.4 M | 16.1 M | 15.6 M | - |
General and Administrative Expenses |
- | - | - | - | - | - | 454 K | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Kewaunee Scientific Corporation
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
2.87 M | 2.87 M | 2.85 M | 2.87 M | 2.87 M | 2.85 M | 2.84 M | 2.87 M | 2.87 M | 2.85 M | 2.84 M | 2.89 M | 2.9 M | 2.86 M | 2.83 M | 2.83 M | 2.83 M | 2.81 M | 2.79 M | 2.76 M | 2.79 M | 2.78 M | 2.76 M | 2.75 M | 2.76 M | 2.76 M | 2.76 M | 2.74 M | 2.75 M | 2.75 M | 2.75 M | 2.72 M | 2.74 M | 2.74 M | 2.74 M | 2.71 M | 2.72 M | 2.72 M | 2.71 M | 2.68 M | 2.71 M | 2.71 M | 2.69 M | 2.63 M | 2.67 M | 2.67 M | 2.63 M | 2.62 M | 2.63 M | 2.63 M | 2.62 M | 2.59 M | 2.61 M | 2.61 M | 2.6 M | 2.58 M | 2.59 M | 2.59 M | 2.58 M | 2.58 M | 2.58 M | 2.58 M | 2.58 M |
Net Income |
692 K | 2.44 M | 3.09 M | 692 K | 1.35 M | 3.09 M | - | 1.35 M | 3.01 M | 2.19 M | - | 2.52 M | 2.73 M | 2.47 M | - | 723 K | -243 K | -747 K | -362 K | 81 K | -3.1 M | -4.44 M | -1.34 M | -1.92 M | -180 K | -180 K | -598 K | -22 K | -2.18 M | -2.18 M | 471 K | 853 K | 1.33 M | 1.49 M | 1.41 M | 341 K | 1.72 M | 1.72 M | 1.15 M | 830 K | 1.49 M | 1.49 M | 1.3 M | 484 K | 695 K | 695 K | 940 K | 604 K | 1.2 M | 1.2 M | 1.23 M | 544 K | 725 K | 725 K | 1.59 M | -122 K | 649 K | 649 K | 634 K | 86 K | -125 K | -125 K | 22 K |
Revenue |
69.4 M | 70.1 M | 71.1 M | 69.4 M | 67.2 M | 71.1 M | - | 67.2 M | 47.8 M | 48.4 M | - | 46.8 M | 50.4 M | 49.8 M | - | 60.8 M | 54.6 M | 50.1 M | 2.79 M | 40.6 M | -3.1 M | -1.34 M | 39.5 M | 34.2 M | 39 M | 39 M | 36.4 M | 32.4 M | 39.7 M | 39.7 M | 39.3 M | 38.2 M | 37.3 M | 42.2 M | 42.2 M | 30.4 M | 41.5 M | 75.4 M | 34.6 M | 32.4 M | 36.3 M | 36.3 M | 37.3 M | 27.8 M | 31 M | 31 M | 31.1 M | 26 M | 30.3 M | 30.3 M | 30.5 M | 27.4 M | 26.1 M | 26.1 M | 32 M | 21.6 M | 31.2 M | 31.2 M | 26.7 M | 22.6 M | 26 M | 26 M | 26.3 M |
Cost of Revenue |
50.9 M | 50.4 M | 50.2 M | 50.9 M | 48.8 M | 50.2 M | - | 48.8 M | 33.8 M | 35.9 M | - | 34.7 M | 37 M | 37.9 M | - | 50.5 M | 45.9 M | 43.9 M | - | 27.7 M | 35.4 M | 69.3 M | - | 28.9 M | 32.6 M | 32.6 M | 30.5 M | 27.1 M | 33.4 M | 33.4 M | 32.4 M | 29.8 M | 29.6 M | 34.6 M | 34.7 M | - | 33.6 M | 60.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
18.5 M | 19.7 M | 20.9 M | 18.5 M | 18.4 M | 20.9 M | - | 18.4 M | 14 M | 12.5 M | - | 12 M | 13.5 M | 11.9 M | - | 10.3 M | 8.7 M | 6.2 M | 9.33 M | 5.65 M | 3.6 M | 9.27 M | 5.67 M | 5.28 M | 6.4 M | 6.4 M | 5.88 M | 5.23 M | 6.32 M | 6.32 M | 6.95 M | 8.31 M | 7.66 M | 7.58 M | 7.47 M | 5.03 M | 7.91 M | 7.91 M | 6.82 M | 5.49 M | 7.1 M | 7.1 M | 7.14 M | 4.46 M | 5.53 M | 5.53 M | 5.84 M | 4.71 M | 5.82 M | 5.82 M | 6.15 M | 5.01 M | 4.89 M | 4.89 M | 6.58 M | 3.77 M | 5.23 M | 5.23 M | 5.24 M | 4.16 M | 3.84 M | 3.84 M | 4.19 M |
Operating Income |
2.58 M | 4.11 M | 4.81 M | 2.58 M | 2.25 M | 4.81 M | - | 2.25 M | 4.43 M | 2.58 M | - | 3.81 M | 5.11 M | 3.81 M | - | 2.3 M | 755 K | -396 K | - | -376 K | -2.89 M | -3.98 M | - | -2.07 M | -11 K | -11 K | -276 K | -2 K | -39 K | -39 K | 776 K | 2.43 M | 1.7 M | 1.82 M | 1.71 M | 442 K | 2.66 M | 2.66 M | 1.69 M | 1.05 M | 2.29 M | 2.29 M | 2.06 M | 584 K | 1.13 M | 1.13 M | 1.52 M | 938 K | 1.87 M | 1.87 M | 1.8 M | 955 K | 1.13 M | 1.13 M | 2.43 M | -219 K | 1.21 M | 1.21 M | 1.1 M | 156 K | -160 K | -160 K | 233 K |
Interest Expense |
- | - | 1.06 M | - | 1.14 M | 1.06 M | - | - | 442 K | 472 K | - | 411 K | 372 K | 430 K | - | 436 K | 370 K | 384 K | - | 105 K | 132 K | 238 K | - | 150 K | 128 K | 128 K | 77 K | 76 K | 135 K | 135 K | 167 K | 78 K | 91 K | 91 K | 91 K | 71 K | 89 K | 89 K | 59 K | 83 K | 78 K | 78 K | 80 K | 91 K | 61 K | 61 K | 92 K | 116 K | 102 K | 102 K | 81 K | 80 K | 72 K | 72 K | 88 K | 110 K | 101 K | 101 K | 114 K | -17 K | 128 K | 128 K | 95 K |
EBITDA |
4.18 M | 5.69 M | 6.36 M | 4.18 M | 5.43 M | 6.36 M | - | 3.81 M | - | 3.39 M | - | - | - | 4.53 M | - | 2.3 M | 755 K | 329 K | - | -376 K | -885 K | -2.58 M | - | -2.07 M | 1.92 M | 1.34 M | 411 K | -2 K | 1.87 M | 1.25 M | 1.42 M | 2.43 M | 3.8 M | 2.45 M | 2.34 M | 442 K | 4.62 M | 4.06 M | 2.37 M | 1.05 M | 4.14 M | 3.59 M | 2.71 M | 584 K | 3.03 M | 2.36 M | 2.14 M | 938 K | 3.72 M | 3.14 M | 2.43 M | 955 K | 3.13 M | 2.38 M | 3.06 M | -219 K | 3.21 M | 2.53 M | 1.76 M | 156 K | 1.66 M | 1.18 M | 910 K |
Operating Expenses |
16 M | 15.6 M | 16.1 M | 16 M | 16.1 M | 16.1 M | - | 16.1 M | 9.52 M | 9.91 M | - | 8.22 M | 8.36 M | 8.11 M | - | 8.03 M | 7.95 M | 6.59 M | - | 6.03 M | 6.49 M | 13.3 M | - | 7.35 M | 6.41 M | 6.41 M | 6.16 M | 5.23 M | 6.36 M | 6.36 M | 6.17 M | 5.97 M | 5.96 M | 5.76 M | 5.76 M | 4.59 M | 5.26 M | 5.26 M | 5.13 M | 4.44 M | 4.82 M | 4.82 M | 5.08 M | 3.87 M | 4.4 M | 4.4 M | 4.32 M | 3.77 M | 3.95 M | 3.95 M | 4.35 M | 4.05 M | 3.76 M | 3.76 M | 4.14 M | 3.99 M | 4.01 M | 4.01 M | 4.14 M | 4.01 M | 4 M | 4 M | 3.96 M |
All numbers in USD currency
The income statement is one of the three key financial reports of a company Kewaunee Scientific Corporation (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.
USA
Italia
